ESC 365 - RIVER: Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation

ESC Professional Premium Access

RIVER: Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation

Session: Late-breaking science on valve disease and hypertrophic cardiomyopathy

Topic: Pharmacotherapy

Speaker: Doctor P. Barros E Silva (Sao Paulo, BR)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Pedro Gabriel Barros E Silva

University Centre Sao Camilo, Sao Paulo (Brazil)

1 presentation

0 follower

3 more presentations in this session

NOTION - The Nordic Aortic Valve Intervention Trial

Speaker: Doctor T. Jorgensen (Copenhagen, DK)

EXPLORER-CN - Efficacy and safety of mavacamten in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy

Speaker: Doctor Z. Tian (Beijing, CN)

VALOR-HCM 56 Week Long-term Extension Study in oHCM

Speaker: Doctor M. Desai (Cleveland, US)

Access the full session

Late-breaking science on valve disease and hypertrophic cardiomyopathy

Speakers: Doctor P. Barros E Silva, Doctor T. Jorgensen, Doctor Z. Tian, Doctor M. Desai

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources